Akebia Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 11/12/2025 | 18.80 M | $51.32 M | 2.30% | 7.16% |
| VANGUARD GROUP INC | 11/07/2025 | 15.55 M | $42.44 M | 6.41% | 5.92% |
| STATE STREET CORP | 11/14/2025 | 11.84 M | $32.34 M | 48.11% | 4.51% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 6.18 M | $16.89 M | 1.82% | 2.36% |
| MORGAN STANLEY | 11/14/2025 | 4.32 M | $11.78 M | -19.19% | 1.64% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 3.95 M | $10.79 M | -5.76% | 1.51% |
| UBS GROUP AG | 11/13/2025 | 3.65 M | $9.95 M | 470.20% | 1.39% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 3.21 M | $8.75 M | 87.00% | 1.22% |
| CITADEL ADVISORS LLC | 11/14/2025 | 3.19 M | $8.70 M | 37.48% | 1.21% |
| BIOIMPACT CAPITAL LLC | 11/14/2025 | 2.89 M | $7.89 M | 0.00% | 1.10% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 2.86 M | $7.80 M | 32.07% | 1.09% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 2.68 M | $7.32 M | 0.48% | 1.02% |
| NORTHERN TRUST CORP | 11/14/2025 | 2.49 M | $6.79 M | 16.45% | 0.95% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 2.45 M | $6.69 M | 25.64% | 0.93% |
| INVESCO LTD. | 11/13/2025 | 2.40 M | $6.55 M | 528.13% | 0.91% |
| NUVEEN, LLC | 11/12/2025 | 2.30 M | $6.28 M | -15.04% | 0.88% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 2.17 M | $5.92 M | 189.75% | 0.83% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 2.15 M | $5.86 M | 59.09% | 0.82% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 2.00 M | $5.46 M | 0.00% | 0.76% |
| CITIGROUP INC | 11/10/2025 | 1.92 M | $5.23 M | 1,324.73% | 0.73% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.79 M | $4.88 M | 61.06% | 0.68% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.77 M | $4.83 M | -55.06% | 0.67% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 1.77 M | $4.82 M | 100.28% | 0.67% |
| BARCLAYS PLC | 11/12/2025 | 1.18 M | $3.22 M | 19.88% | 0.45% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/13/2025 | 1.02 M | $2.79 M | -13.56% | 0.39% |
| JPMORGAN CHASE & CO | 11/26/2025 | 994.18 K | $2.71 M | -39.85% | 0.38% |
| FMR LLC | 11/13/2025 | 911.82 K | $2.49 M | 12.02% | 0.35% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 869.80 K | $2.37 M | 25.02% | 0.33% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 858.54 K | $2.34 M | 64.90% | 0.33% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 778.53 K | $2.13 M | 382.98% | 0.30% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 679.24 K | $1.85 M | 10.34% | 0.26% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/17/2025 | 662.53 K | $1.81 M | -45.02% | 0.25% |
| FEDERATED HERMES, INC. | 11/03/2025 | 639.37 K | $1.75 M | 3.57% | 0.24% |
| SWISS NATIONAL BANK | 11/13/2025 | 509.30 K | $1.39 M | 100.00% | 0.19% |
| AQUATIC CAPITAL MANAGEMENT LLC | 11/14/2025 | 506.91 K | $1.38 M | 942.31% | 0.19% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 492.33 K | $1.34 M | -37.79% | 0.19% |
| RAFFERTY ASSET MANAGEMENT, LLC | 11/12/2025 | 481.87 K | $1.32 M | 89.75% | 0.18% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 442.47 K | $1.21 M | 3.88% | 0.17% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/07/2025 | 426.77 K | $1.17 M | 100.00% | 0.16% |
| RHUMBLINE ADVISERS | 11/06/2025 | 358.67 K | $979.16 K | -1.74% | 0.14% |
| JUMP FINANCIAL, LLC | 11/13/2025 | 355.84 K | $971.45 K | 100.00% | 0.14% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 349.28 K | $953.53 K | 288.36% | 0.13% |
| UBS ASSET MANAGEMENT AMERICAS INC | 11/14/2025 | 326.96 K | $892.60 K | 1,097.43% | 0.12% |
| VICTORY CAPITAL MANAGEMENT INC | 11/12/2025 | 286.39 K | $781.83 K | 853.60% | 0.11% |
| CREATIVE PLANNING | 11/14/2025 | 282.50 K | $771.21 K | -0.29% | 0.11% |
| PRUDENTIAL FINANCIAL INC | 11/13/2025 | 280.56 K | $765.92 K | -32.42% | 0.11% |
| MACKENZIE FINANCIAL CORP | 11/13/2025 | 265.28 K | $724.21 K | 6.71% | 0.10% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 11/14/2025 | 247.70 K | $676.22 K | 1,543.34% | 0.09% |
| LEGAL & GENERAL GROUP PLC | 11/13/2025 | 245.25 K | $669.53 K | 953.53% | 0.09% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 238.93 K | $652.28 K | 0.00% | 0.09% |
Akebia Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 239 institutional investors and hedge funds held shares of Akebia Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 18.8 M
VANGUARD GROUP INC: 15.55 M
STATE STREET CORP: 11.84 M
GEODE CAPITAL MANAGEMENT, LLC: 6.18 M
MORGAN STANLEY: 4.32 M
RENAISSANCE TECHNOLOGIES LLC: 3.95 M
47.10% of Akebia Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 146.70 M shares in the last 24 months. This purchase volume represents approximately $415.17 M in transactions.